Physician
New York City Health and Hospitals Corporation
New York City Health and Hospitals Corporation was paid $14.70M by Medicaid between Jan 2018 and Dec 2024, across 177 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 17% of everything it billed.
33Billing provider infoNEW YORK CITY HEALTH AND HOSPITALS CORPORATION
NEW YORK, NY 10026
NEW YORK, NY 10026
33aNPI1235147497assigned 08/04/2006
33bProvider typeInternal Medicine Physician
28Total paid$14.70M
24GClaims430,299
24DCodes billed177
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in New York
Rank by total paid#20 of 6,049
Median peer was paid$11K
This provider vs. median1,300×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,829 | $259K | |
| 2019 | 42,792 | $1.12M | |
| 2020 | 94,223 | $3.85M | |
| 2021 | 117,132 | $4.01M | |
| 2022 | 56,986 | $1.92M | |
| 2023 | 60,862 | $1.96M | |
| 2024incomplete | 54,475 | $1.57M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 30,325 | 24,356 | $2.54M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 10% | 20,323 | 17,207 | $1.52M |
| 99442 | 6.8% | 11,845 | 11,282 | $993K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.7% | 9,100 | 8,233 | $991K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.9% | 12,065 | 10,734 | $864K |
| 36415 | Collection of venous blood by venipuncture | 4.7% | 72,621 | 20,446 | $697K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.7% | 11,918 | 9,000 | $542K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.2% | 20,119 | 17,750 | $318K |
| 99201 | 2.1% | 3,955 | 3,846 | $302K | |
| 99441 | 2.0% | 4,696 | 4,468 | $296K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.8% | 2,686 | 2,384 | $264K |
| 99443 | 1.8% | 2,493 | 2,422 | $258K |
165 more codes
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 1.6% | 5,328 | $240K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.6% | 2,536 | $238K |
| D0999 | Unspecified diagnostic procedure, by report | 1.5% | 1,344 | $215K |
| 99215 | Doctor's office visit, returning patient (complex) | 1.4% | 1,770 | $213K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.4% | 6,447 | $204K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.3% | 10,717 | $189K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.3% | 6,278 | $186K |
| 86769 | 1.2% | 6,779 | $178K | |
| 90750 | 1.2% | 1,056 | $177K | |
| D9999 | Unspecified adjunctive procedure, by report | 1.2% | 1,204 | $171K |
| 99203 | Doctor's office visit, new patient (routine) | 1.1% | 1,452 | $167K |
| 86480 | <1% | 2,255 | $138K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,136 | $138K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 723 | $120K |
| 80061 | Lipid panel | <1% | 10,403 | $114K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,053 | $113K |
| 90677 | <1% | 545 | $105K | |
| 90651 | <1% | 1,058 | $98K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,336 | $94K |
| 86703 | <1% | 6,822 | $94K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 2,366 | $86K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 11,406 | $85K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 673 | $78K |
| 90686 | <1% | 4,529 | $72K | |
| 92551 | <1% | 1,285 | $69K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,437 | $69K |
| 86780 | <1% | 5,103 | $63K | |
| 80053 | Comprehensive metabolic panel | <1% | 5,329 | $62K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,595 | $62K |
| 85027 | <1% | 12,427 | $62K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 3,017 | $54K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,223 | $47K |
| 90715 | <1% | 1,615 | $47K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 570 | $46K |
| 0012A | <1% | 1,101 | $43K | |
| 80076 | <1% | 5,121 | $42K | |
| 86803 | <1% | 3,548 | $42K | |
| 90461 | <1% | 820 | $40K | |
| 0011A | <1% | 1,189 | $38K | |
| 96116 | <1% | 296 | $37K | |
| 96127 | <1% | 6,134 | $36K | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 256 | $35K |
| 90746 | <1% | 526 | $31K | |
| 90620 | <1% | 387 | $30K | |
| 96112 | <1% | 309 | $28K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 816 | $27K |
| 81001 | <1% | 6,900 | $25K | |
| 97802 | <1% | 867 | $24K | |
| 82728 | <1% | 1,924 | $23K | |
| 82607 | <1% | 1,646 | $21K | |
| D1110 | Prophylaxis - adult | <1% | 1,080 | $21K |
| 99051 | <1% | 938 | $20K | |
| 3074F | <1% | 8,052 | $20K | |
| 83655 | <1% | 1,249 | $16K | |
| 87340 | <1% | 1,685 | $16K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 524 | $15K |
| 92250 | <1% | 322 | $14K | |
| 90732 | <1% | 135 | $14K | |
| 86706 | <1% | 1,343 | $13K | |
| D0274 | Bitewings - four radiographic images | <1% | 1,227 | $13K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 131 | $12K |
| 91322 | <1% | 142 | $12K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 527 | $12K |
| 90480 | <1% | 260 | $11K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 614 | $11K |
| 83550 | <1% | 1,611 | $11K | |
| 82043 | <1% | 2,083 | $11K | |
| 99401 | <1% | 319 | $11K | |
| 84153 | <1% | 661 | $10K | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 905 | $10K |
| 83540 | <1% | 1,830 | $10K | |
| 81025 | <1% | 1,658 | $9K | |
| 82274 | <1% | 793 | $9K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 246 | $8K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 1,661 | $8K |
| 99385 | <1% | 62 | $8K | |
| 84439 | <1% | 992 | $8K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 384 | $8K |
| 86765 | <1% | 631 | $8K | |
| 86762 | <1% | 557 | $8K | |
| 88142 | <1% | 339 | $7K | |
| G0467 | Community health center visit, returning patient | <1% | 1,780 | $7K |
| 97803 | <1% | 336 | $7K | |
| 86704 | <1% | 641 | $7K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 774 | $6K |
| 82652 | <1% | 123 | $6K | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 119 | $6K |
| T2022 | Case management, per month | <1% | 97 | $5K |
| 90656 | <1% | 374 | $5K | |
| 86735 | <1% | 508 | $5K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 16 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 726 | $5K |
| 86787 | <1% | 487 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 327 | $5K |
| 84703 | <1% | 264 | $4K | |
| 83020 | <1% | 245 | $4K | |
| D0120 | Dental checkup, returning patient | <1% | 384 | $4K |
| 90734 | <1% | 209 | $4K | |
| 90662 | <1% | 135 | $3K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 907 | $3K |
| 82746 | <1% | 221 | $3K | |
| 81003 | <1% | 1,112 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 62 | $2K |
| 84702 | <1% | 173 | $2K | |
| D0330 | Panoramic radiographic image | <1% | 354 | $2K |
| 87800 | <1% | 69 | $2K | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 13 | $2K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 14 | $2K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 151 | $2K |
| 99384 | <1% | 12 | $2K | |
| 90670 | <1% | 26 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 13 | $2K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 53 | $1K |
| 90653 | <1% | 52 | $1K | |
| 99383 | <1% | 12 | $1K | |
| 90694 | <1% | 38 | $1K | |
| 86140 | <1% | 298 | $1K | |
| D1206 | Topical application of fluoride varnish | <1% | 85 | $1K |
| 99381 | <1% | 58 | $1K | |
| 85651 | <1% | 260 | $790.41 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 26 | $764.32 |
| D1120 | Dental cleaning, child | <1% | 40 | $726.79 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 13 | $686.00 |
| 86696 | <1% | 31 | $520.46 | |
| 0124A | <1% | 12 | $502.10 | |
| 90633 | <1% | 43 | $463.27 | |
| 87486 | <1% | 16 | $428.82 | |
| 87581 | <1% | 16 | $390.52 | |
| 86695 | <1% | 31 | $386.15 | |
| 82550 | <1% | 80 | $376.41 | |
| 82947 | <1% | 83 | $376.14 | |
| 99188 | <1% | 14 | $339.57 | |
| 83001 | <1% | 12 | $235.98 | |
| 86580 | <1% | 25 | $232.14 | |
| 83921 | <1% | 12 | $226.94 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 314 | $225.42 |
| 91319 | <1% | 20 | $210.21 | |
| 82465 | <1% | 63 | $198.55 | |
| 83090 | <1% | 12 | $191.73 | |
| 87081 | <1% | 26 | $188.54 | |
| 90710 | <1% | 12 | $175.70 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 78 | $174.78 |
| Q3014 | Telehealth originating site facility fee | <1% | 15 | $156.51 |
| 86592 | <1% | 51 | $139.23 | |
| 85045 | <1% | 40 | $135.47 | |
| 96161 | <1% | 29 | $113.58 | |
| 86708 | <1% | 12 | $99.85 | |
| D0140 | Limited oral evaluation - problem focused | <1% | 14 | $60.10 |
| 3078F | 0% | 7,013 | $0.00 | |
| 99499 | 0% | 496 | $0.00 | |
| 3077F | 0% | 1,428 | $0.00 | |
| 1160F | 0% | 374 | $0.00 | |
| 1159F | 0% | 533 | $0.00 | |
| G0466 | Community health center visit, new patient | 0% | 53 | $0.00 |
| 99080 | 0% | 25 | $0.00 | |
| 90658 | 0% | 30 | $0.00 | |
| 3075F | 0% | 1,944 | $0.00 | |
| 3079F | 0% | 2,939 | $0.00 | |
| 3080F | 0% | 423 | $0.00 | |
| D1330 | 0% | 197 | $0.00 | |
| S9451 | Exercise classes, non-physician provider, per session | 0% | 99 | $0.00 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 163 | $0.00 |
| 1220F | 0% | 109 | $0.00 | |
| D1208 | Topical application of fluoride, excluding varnish | 0% | 13 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHAN, MIN (SR. DIRECTOR)